Prescribing Advice for GPs

An NHS Prescribing Advisers' Blog

Cilest to be discontinued

The manufacturer of Cilest® (norgestimate and ethinyl estradiol) has written to healthcare professionals advising that this product will be discontinued with effect from July 2019.

The letter states that this was a commercial decision to exit the oral hormonal contraceptive market and it is stressed that the are no safety, efficacy or quality issues with the product. Current supplies are expected to last until mid-July 2019.

There are two alternative products that are currently available in the UK with the same active ingredients - Cilique® and Lizinna®.

Action: Clinicians should be aware of this product being discontinued. It would be prudent to run clinical system searches to identify any patients who are currently prescribed this product to allow a review and arrangements made to identify a suitable alternative.

Both Cilique and Lizinna (and other OCP brands) are available privately from UK regulated online clinics such as Dr Fox Pharmacy.
This product or service is not endorsed by

Share 'Cilest to be discontinued' on Email Share 'Cilest to be discontinued' on Delicious Share 'Cilest to be discontinued' on Digg Share 'Cilest to be discontinued' on Facebook Share 'Cilest to be discontinued' on reddit Share 'Cilest to be discontinued' on Twitter


2 Comments to “Cilest to be discontinued”

  1. Can I ask that it does not get discontinued. My last pack went missing out of my top drawer and me and my family have used it for years - really annoying. I do not want another version of it - I want that re-prescribed to me.


    Comment by Crystal Astrid Palmer Tompkinson — May 14, 2019 #

    1. @Crystal,

      I'm not the manufacturer and have no control over this product.

      Comment by Matthew Robinson — May 14, 2019 #

Leave a Comment

Your email address will not be published. Required fields are marked *

This site uses Akismet to reduce spam. Learn how your comment data is processed.

Prescribing Advice for GPs is powered by ClassicPress.
Subscribe for Free to our RSS or Atom Feeds for New Entries.